ABIVAX Société Anonyme (EPA:ABVX)
France · Delayed Price · Currency is EUR 85.05
-1.15 (-1.33%)
Jun 19, 2026, 5:35 PM CET
ABIVAX Société Anonyme Market Cap
ABIVAX Société Anonyme has a market cap or net worth of €6.78 billion as of June 18, 2026. Its market cap has increased by 1,508.70% in one year.
Market Cap
6.78B
Enterprise Value
6.32B
Revenue
4.92M
Ranking
n/a
PE Ratio
n/a
Stock Price
€85.05
Market Cap Chart
Since June 26, 2015, ABIVAX Société Anonyme's market cap has increased from 202.12M to 6.78B, an increase of 3,253.42%. That is a compound annual growth rate of 37.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 6.78B | -27.67% |
| Dec 31, 2025 | 9.37B | 2,088.64% |
| Dec 31, 2024 | 428.15M | -30.40% |
| Dec 29, 2023 | 615.18M | 493.46% |
| Dec 30, 2022 | 103.66M | -77.81% |
| Dec 31, 2021 | 467.16M | -1.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nanobiotix | 1.56B |
| MedinCell | 884.68M |
| DBV Technologies | 861.70M |
| Inventiva | 648.05M |
| Genfit | 497.95M |
| Valneva SE | 441.69M |
| Transgene | 205.41M |
| Cellectis | 199.36M |